S.Amdt. 5412Senate117th Congress (2021-2023)2nd degree
S.Amdt. 5412
Sponsored by
Sen. John Barrasso (R-WY)
Submitted August 6, 2022
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
August 6, 2022
Text
Submitted
SA 5412. Mr. BARRASSO (for himself, Ms. Collins, and Mr. Wicker) submitted an amendment intended to be proposed to amendment SA 5194 proposed by Mr. Schumer to the bill H.R. 5376, to provide for reconciliation pursuant to title II of S. Con. Res. 14; which was ordered to lie on the table; as follows: At the end of title I, add the following: Subtitle E--Ensuring Access to Drugs and Biological Products That Treat Rare Diseases and Conditions SEC. 14001. ENSURING ACCESS TO DRUGS AND BIOLOGICAL PRODUCTS THAT TREAT RARE DISEASES AND CONDITIONS. Sec. 1192(e)(3)(A) of the Social Security Act, as added by section 11001, is amended to read as follows: ``(A) Certain orphan drugs.--A drug that is designated under section 526 of the Federal Food, Drug, and Cosmetic Act for a rare disease or condition and is approved only for an indication or indications for a rare disease or condition.''. SEC. 14002. REDUCTION OF ADDITIONAL IRS FUNDING FOR OPERATIONS SUPPORT. Section 10301(a)(1)(A)(i)(III) of this Act is amended by striking ``$25,326,400,000'' and inserting ``$10,326,400,000''. ______